-/-clones were selected by qPCR for p53 genomic DNA fragment (clones 2-4, 6-8, 2% knockout efficiency). b. Southern blot after Hind III digestion of genomic DNA of selected clones. Fragments corresponding to the wild-type allele (p53 +/+ ) (2.5 kb) or p53 -/-clones (clones 3 and 4) are shown. ZFN oligonucleotide probe (ZFN cut site) or wild-type exon 3 probe (outside of ZFN cut site) were used. c. p53
-/-clones (clones 3 and 4) were verified by Northern blot analysis. Total RNA was subjected to Northern blot analysis, using the indicated cDNA probes. d. ZFN cutting sites in exon 3 of p53 gene and p53 -/-sequencing result (clone 3). e & f. Morphology and immunostaining for p53 +/+ IMR90 fibroblasts 4 weeks after applying neuronal media. p53 +/+ cells still kept fibroblast morphology (e). GFAP, O4, and MAP2 negative staining (f). g. p53 -/-mouse embryonic fibroblasts MEFs from p53 knockout mouse show iN cells 3 weeks after applying neuronal media. Tuj1, MAP2 and Synapsin positive staining of iN cells. h. Quantitative analysis of iN cells from p53 -/-and p53 +/+ MEFs on indicated days after applying neuronal media. Scale bar, 10 µm (e, f & g). . mRNA expression levels of these factors were determined by qRT-PCR. The bar for hAscl1 corresponds to +A, for hBrn2 corresponds to +B, and for hNeurod2 corresponds to +D. The P values are <0.01, based on Student's t test. e. mRNA expression of p53 in young and old IMR90 cells. mRNA expression levels of p53 were determined by qRT-PCR in population doublings, PD10, PD30 and PD55 IMR90 cells. The P value is based on Student's t test. f. p53 binds to the Neurod2 promoter. Quantitative PCR assays for ChIP from p53 +/+ and p53 -/-IMR90 cells. p53 binding to the Neurod2 (chr17, 37763017-37763037), Ascl1 and Brn2 was tested by ChIP. p53 binding to p21 was used as positive control. g and h. Quantitative PCR assays for mRNA expression and ChIP from SH-SY5Y (a human neuroblastoma cell line with wild-type p53). p21 and GAPDH were used as positive and negative controls. Dox: Doxorubicin. i. Quantitative data of iN cells from IMR90 cells with expressions of shp53 and shNeurod2. Scale bar, 10 µm (b & c).
2.

Supplemental Experimental Procedures
Cell culture
Human fibroblasts (IMR90, adult dermal and neonatal foreskin from ATCC) and mouse fibroblasts were routinely cultured in 60 mm dish (MidSci) in DMEM medium ((Dulbecco's modified Eagle medium (DMEM; Hyclone) containing 10% fetal bovine serum (FBS; Sigma), non-essential amino acids (Invitrogen) and penicillin/streptomycin (Invitrogen)) at 37 °C in 5% CO 2 . Primary normal human Bronchial/Tracheal Epithelial Cells were from ATCC (PCS-300-010 ™ ).
Neural cell conversion
For neuronal conversion, modified fibroblasts were plated in DMEM medium at a density of 3.0X10 4 cells per cm 2 on microscope glass coverslips coated with Matrigel (BD) or Laminin (Roche) and Fibronectin (Sigma) in 35 mm dish. Four days after infection, the media was changed to Neuronal Media (ScienCell, #1521) plus 0.5 mM Dibutyryl cyclic-AMP sodium salt (dbcAMP, Sigma), and 20 ng ml −1 basic Fibroblast Growth Factor (bFGF, ScienCell). Culture medium was changed every 4 days. We also added 10 ng ml −1 human Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3 (NT-3) (both from PROSPEC) after 1 weeks to the medium to enhance induced cell survival. We also use a modified N3 medium as induction medium and observed the similar results as those using Neuronal Media (ScienCell). The modified N3 medium includes DMEM/F12 (Invitrogen), 100 µg ml −1 apotransferrin, 5 µg ml
insulin, 30 nM sodium selenite, 2.5 μg/ml fibronectin, 20 nM progesterone, 100 nM putrescine, 0.5 mM Dibutyryl cyclic-AMP sodium salt (dbcAMP, Sigma), 20 ng ml −1 basic Fibroblast Growth Factor (bFGF, ScienCell), 10 ng ml −1 human Brain-Derived Neurotrophic Factor (BDNF, PROSPEC), 10 ng ml −1 Neurotrophin-3 (NT-3, PROSPEC), penicillin/streptomycin. For astrocyte induction, we used Astrocyte Medium from ScienCell (#1801). We calculated the induction efficiencies using the numbers represent the percentage of induced neural cells at the time point of quantification (n=1000, 20 random visual fields/3 wells for each sample). Quantitative of iN cells is counted by Tuj1 (early stage, before one week induction) and MAP2 (late stage, after 1 week induction) positive staining, astrocytes by GFAP and oligodendrocytes by O4 positive staining. Quantitative data are mean ± s.e.m from five biologically independent experiments.
Cortical neuron culture and co-culture with iNs
Primary cortical neurons were isolated from P0 rat. Cortices were dissected and dissociated by trypsin digestion (0.25% Trypsin, 137 mM NaCl, 5 mM KCl, 7 mM Na 2 HPO 4 , 25 mM HEPES) and plated on poly-D-lysine coated glass coverslips. The neurons were maintained in growth media consisting of MEM supplemented with B27, glutamine (all from Invitrogen), glucose, transferrin (Calbiochem), FBS and Ara-C (both from Sigma) for a week before coculture with iNs. iN cells were labeled with expression of a lentiviral-GFP vector. iNs were induced for 7 days by Neuronal medium (ScienCell), 20 ng/ml human bFGF and dissociated by trypsin digestion (0.05% Trypsin). Then iN cells were seeded onto cortical neurons bed and maintained in Mature Medium (Induction Medium with 0.5 mM dbcAMP, 10 ng/ml BDNF, 10 ng/ml NT3). Mature Medium was replaced every two days.
Viral preparation and western blot
cDNA of neural transcription factors Ascl1, Brn2, NeuroD2, Myt1l and miR9-124 were gifts from Andrew S. Yoo. The following shRNAs (Sigma) were used: shp53-A at cDNA (accession number NM_000546), positions 941-961; shp53-B at 3'UTR, positions 1673-1693; : shp21-A at cDNA (accession number NM_000389), positions 526-546; shp21-B at 3'UTR, positions 640-660; shp21-A at cDNA (accession number NM_000389), positions 526-546; shp21-B at 3'UTR, positions 640-660; shAscl1-A at cDNA (accession number NM_004316), position 884-903; shAscl1-B at 3'UTR position 1405-1425; shBrn2-A at cDNA (accession number NM_005604), position 1137-1157; shBrn2-B at 3'UTR, position 1572-1592; shNeurod2-A at cDNA (accession number NM_006160), position 1266-1186; shNeurod2-B at 3'UTR, position 1804-1824. Western blotting analyses were performed to check the knock down efficiency, as described previously (Sun et al., 2014a; Yang et al., 2007) .
Immunofluorescence
Immunofluorescence staining was performed as previously described (Jia et al., 2013; Xiang et al., 2008; Xiang et al., 2011) . Briefly, 5 × 10 4 modified human fibroblasts were planted on Matrigel-coated glass coverslips the day before induction. 10-28 days after viral infection cells were fixed for 20 min at room temperature in 4% paraformaldehyde in PBS, permeabilized for 30 min in PBS containing 0.2% Triton X-100 and 10% normal goat serum (NGS), and incubated overnight at 4 °C in PBS containing 10% NGS and primary antibodies. Then cells were washed three times with PBS and incubated for 2 h at room temperature with anti-rabbit or anti-mouse secondary antibodies Alexa Fluor-488 or Alexa Fluor-594 (1:500, Invitrogen). The images were acquired by immunofluorescence microscope or Zeiss LSM 510 META confocol microscope with 40X, 1.3 numerical aperture oil-immersion objective.
The following antibodies were used for the immunofluorescence studies: rabbit anti-MAP2 (Sigma-Aldrich, 1:200), mouse anti-Tuj1 (R&D Systems, 1:100), rabbit anti-synapsin 1 (Cell Signaling, 1:200), Rabbit anti-synapsin (1:1000, Millipore), Guinea pig anti-vGluT1 (1:5000, Millipore), rabbit anti-GABA (1: 3000, Sigma), mouse anti-peripherin (1:100, Millipore), mouse anti-tyrosine hydroxylase (1:8000, Sigma), mouse anti-Oct-3/4(C-10) (1:200, Santa Cruz), goat anti-Sox-2 (Y-17) (1:100, Santa Cruz), mouse anti-Nestin (R&D Systems, 1:100), goat anti-TBR-1 (1:1000, I-18, Santa Cruz, sc15607), rabbit anti-HOXB9 (1:100, Abcam), mouse anti-human nuclei (1:200, Millipore). To verify specificity of TBR1 antibody, immunizing peptide blocking experiment was performed. Before proceeding with the staining protocol, the antibodies were incubated with excess of peptides (1 μg/ml) that correspond to the epitope recognized by the antibody (Santa Cruz, TBR1 peptide sc-15607 P).
RNA preparation and qRT-PCR
Total RNA was extracted using Trizol isolation system (Invitrogen) according to manufacturer's instructions. Total RNA was treated with DNase I (Qiagen) to prevent DNA contamination. Two micrograms of RNA were reverse transcribed using the Transcriptor High Fidelity cDNA Synthesis Kit (Roche). Reverse transcription and real-time PCR were performed as described previously (Sun et al., 2014b; Zheng et al., 2014) .
ChIP assays
Cells were cultured in 15-cm plates and a ChIP assay was performed using ChIP assay kit (Upstate) according to the manufacturer's instructions. One microgram of p53 DO7 was used per ChIP. ChIP sample DNA was purified and precipitated. PCR primers were designed for Neurod2 to cover three p53 binding sites in the promoter of Neurod2 (NC_000017.10), including chr17, 37761792-37761812 (+ strand), 37762804-37762814 (-strand) and 37763017-37763037 (+ strand). Primers for the Ascl1 and Brn2 promoters were used as describe previously. Quantitative PCR was performed as described previously (Yang et al., 2005; Zeng et al., 2009 ).
Knockout of p53 by zinc finger nucleases (ZFNs) in IMR90 cells
CompoZr Knockout Zinc Finger Nucleases targeting human p53 were from Sigma. p53 ZFN-mRNAs were transfected into IMR90 cells and Cel-I assay was performed to check efficiency of depleting p53. The cells were plated in100mm dish for single clone formation. The 300 single cell clones were picked and cultured. Six p53 -/-clones were selected by qPCR. The correctly targeted clones were identified by Southern blot hybridization of genomic DNA, with two different probes. p53 -/-clones were further verified by Northern, Western blot analysis and genomic DNA sequence.
Electrophysiology
Coverslips with iNs were placed in the recording chamber mounted on an Olympus 1x81 microscope. All electrophysiology recordings were recorded at room temperature (22-25 ºC) via whole-cell recording with a patch electrode. Signals were amplified using Heka EPC-10 amplifier and filtered at 2 KHz via a Bessel low-pass filter. Data were samples using Puls8.8 software, and analyzed using Igor6.04.
For recording voltage-gated currents and action potentials, patch electrodes were filled with solution (in mM): 130 K-gluconate, 10 KCl, 10 HEPES, 0.5 EGTA, 4 MgATP, 0.3 Na2GTP, 10 P-Creatin, pH adjusted by KOH to 7.2, osmolarity measured at 310 mOsm. The composition of the external solution used for recording was as follows (in mM): 105 NaCl, 25 NaHCO3, 3 Myo-Inositol, 2 Na-Pyruvat, 2.5 KCl, 1.25 NaH2PO4, 25 Glucose, 2 CaCl2, 1.5 MagCl2, pH adjusted by NaOH to 7.4, osmolarity measured at 300 mOsm. To monitor voltagegated currents, we applied step potentials ranging from -60mV to +60 mV for 20 ms. To monitor action potentials, we applied step currents ranged from 10-100 pA for 500ms. L-Glutamate and GABA were prepared in bath solution and applied by an electrode placed 50-70 μm from the cells. External solutions changes were achieved rapidly, within 100 ms. Excitatory and inhibitory postsynaptic currents were isolated by adding picrotoxin (100 µM) to block the GABA A receptor or D-APV (50 µM) and CNQX (20 µM) to block the NMDA and AMPA receptors respectively.
iN cells transplantation in mice and IHC analysis
We implanted shp53-iN cells in the corpus callosum of SCID mice. On the day of transplantation, cells were harvested with accutase, counted, and resuspended at concentration of 25,000 cells/µL. Four microliters of cell suspension was injected into corpus callosum of mice using the following stereotactic co-ordinates (in reference to Bregma point): 10.98 mm (anterioposterior axis), 21.75 mm (lateromedial axis), 22.25mm (vertical axis). Mice with transplantation of iN cells were perfusion fixated at 1, 2 weeks and 4 months for IHC analysis. Brains were excised and sectioned on a cryostat for immunohistochemical analysis of the cell implants. Implanted cells were identified by their inclusion of GFP. The primary antibodies were used described in antibody section. Subsequently, various fluorescent secondary antibodies were used to visualize the specific primary immunoreaction product in single and double immunohistochemical stainings.
Microarray analysis
RNA was prepared as described in qRT-PCR section. Microarray analysis was performed at the Washington University Genome Center. Briefly, Illumina HumanHT-12 v4 Expression BeadChip was used and samples were labeled by biotin. The Direct Hybridization Assay was performed and the data were scanned on the BeadArray Reader. Scanned images were quantitated by Illumina Beadscan, v3. Quantitative data was imported into Illumina GenomeStudio software and normalized by Illumina's quantile method. The quantile-normalized background-subtracted data were calculated in excel. The data were filtered based on the average signal, and set the baseline as 50 so that only the genes of which average signal >50 could be used for further analysis. To each gene, maximum and minimum signal values were selected, and then divided between them. Only the genes of the division value >4 were selected and considered as differently expressed. All of the differently expressed genes were clustered by using MeV software.
To determine the relationship between the changed genes in different samples and human neuron differentiation genes, human neuron differentiation genes (GO: 0030182) were used by Gene Ontology website Amigo (http://www.geneontology.org/). Compared each sample to wildtype IMR90 fibroblasts, the average signal was set 2 as a baseline. 4-folds as threshold were set to select genes as differently expressed genes. The iN cells derived from shp53, shp53 iN-7 (Day 7) and iN-21 (Day 21) were compared with fibroblasts and iN cells derived from miR-9-124+Ascl1/NeuroD2/Myt1l.
To investigate the effect on 3 germ layers in the induction process, specific genes of ectoderm (GO: 0007398, GO: 0071696, and some common early ectoderm lineage markers), endoderm (GO: 0007492) and mesoderm (GO: 0007498) from Amigo were selected. The average signal was set 2 as a baseline and 2-folds as threshold were set to calculate the percentage of changed genes relative to IMR90. To analyze changes of the fibroblasts associated genes (GO: 0048144, GO: 0048145, GO: 0017134, GO: 0008543), the same method was used.
